|
Delayed
OTC Markets
11:01:47 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 1.210 USD | +2.54% |
|
+6.14% | +17.48% |
Company Valuation: Dr. Martens plc
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,520 | 1,360 | 844 | 502.5 | 603.6 | 841.3 | - | - |
| Change | - | -46.04% | -37.94% | -40.47% | 20.12% | 39.38% | - | - |
| Enterprise Value (EV) 1 | 2,686 | 1,648 | 1,202 | 748.3 | 816.8 | 1,038 | 1,006 | 976.5 |
| Change | - | -38.63% | -27.11% | -37.72% | 9.16% | 27.07% | -3.05% | -2.95% |
| P/E | 13.9x | 10.5x | 12.5x | 104x | 26x | 17.8x | 14.3x | 12.2x |
| PBR | 7.7x | 3.36x | 2.35x | 1.37x | 1.69x | 2.16x | 1.94x | 1.71x |
| PEG | - | -0.4x | -0.3x | -1.1x | 0x | 0x | 0.6x | 0.7x |
| Capitalization / Revenue | 2.77x | 1.36x | 0.96x | 0.64x | 0.79x | 1.07x | 1.02x | 0.97x |
| EV / Revenue | 2.96x | 1.65x | 1.37x | 0.95x | 1.07x | 1.32x | 1.22x | 1.13x |
| EV / EBITDA | 10.2x | 6.73x | 6.08x | 6.4x | 5.53x | 6.42x | 5.63x | 5.02x |
| EV / EBIT | 11.7x | 9.35x | 9.83x | 20.2x | 10.3x | 11.4x | 9.5x | 8.23x |
| EV / FCF | 20.3x | 63.6x | 8.61x | 4.21x | 6.24x | 22.6x | 17x | 15x |
| FCF Yield | 4.92% | 1.57% | 11.6% | 23.7% | 16% | 4.43% | 5.89% | 6.66% |
| Dividend per Share 2 | 0.055 | 0.0584 | 0.0255 | 0.0255 | 0.0255 | 0.025 | 0.0254 | 0.0254 |
| Rate of return | 2.18% | 4.3% | 2.91% | 4.89% | 4.09% | 2.84% | 2.89% | 2.89% |
| EPS 2 | 0.181 | 0.129 | 0.07 | 0.005 | 0.024 | 0.0494 | 0.0615 | 0.072 |
| Distribution rate | 30.4% | 45.3% | 36.4% | 510% | 106% | 50.6% | 41.2% | 35.3% |
| Net sales 1 | 908.3 | 1,000 | 877.1 | 787.6 | 764.9 | 783.6 | 821.8 | 863.2 |
| EBITDA 1 | 263 | 245 | 197.5 | 117 | 147.7 | 161.6 | 178.7 | 194.4 |
| EBIT 1 | 229.3 | 176.2 | 122.2 | 37 | 79.3 | 91.06 | 105.9 | 118.6 |
| Net income 1 | 181.2 | 128.9 | 69.2 | 4.5 | 23.8 | 48.53 | 60.18 | 70.35 |
| Net Debt 1 | 165.8 | 288.3 | 357.5 | 245.8 | 213.2 | 196.7 | 165 | 135.2 |
| Reference price 2 | 2.5200 | 1.3590 | 0.8775 | 0.5210 | 0.6240 | 0.8790 | 0.8790 | 0.8790 |
| Nbr of stocks (in thousands) | 1,000,111 | 1,000,770 | 961,879 | 964,499 | 967,344 | 957,113 | - | - |
| Announcement Date | 6/1/22 | 6/1/23 | 5/30/24 | 6/5/25 | 5/19/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.37x | 1.85x | 7.96x | -.--% | 12.68B | ||
| 18.96x | 2.98x | 9.76x | -.--% | 7B | ||
| 10.08x | 1.76x | 7.22x | -.--% | 6.32B | ||
| 12.07x | 1.38x | 6.64x | 5.53% | 5.96B | ||
| 12.81x | 0.33x | 4.48x | 5.74% | 2.81B | ||
| 7.4x | - | - | - | 2.33B | ||
| 12.94x | 1.06x | 9.51x | 1.91% | 1.73B | ||
| 12x | 1.62x | 7.53x | 4.24% | 1.45B | ||
| 13.79x | 1.05x | 7.33x | 4.69% | 1.31B | ||
| Average | 12.49x | 1.50x | 7.55x | 2.76% | 4.62B | |
| Weighted average by Cap. | 12.90x | 1.79x | 7.74x | 1.65% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DOCS Stock
- DOCMF Stock
- Valuation Dr. Martens plc
Select your edition
All financial news and data tailored to specific country editions
















